Clinical Trial Update: Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab

View source ↗

Summary

Biomarker analyses from patients with diffuse large B-cell lymphoma treated with combination chemotherapy with or without rituximab are reported. The study NCT0…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Lymphoma | Status: COMPLETED